What Counts as a Psychedelic?
There is little consensus in defining “psychedelic.” Yet, research on and access to these substances hinges on what gets included under this umbrella.

There is little consensus in defining “psychedelic.” Yet, research on and access to these substances hinges on what gets included under this umbrella.

Further action is needed to prevent discrimination in health care services towards persons with addiction.

A combination of high demand and a patent monopoly has created a perfect storm of profitability for Janssen’s Spravato.

Patient-reported outcome measures have potential benefits, but raise concerns as well. This article reviews the legal landscape for PROMs.

Psychedelics hold promise to address an array of conditions, but potential benefits may be stratified along the lines of socioeconomic status.

Algorithms used in health care have the potential to improve health outcomes but are susceptible to racial bias.
